Submission for OMB Review; 30-Day Comment Request National Cancer Institute (NCI) A Generic Submission for Formative Research, Pretesting and Customer Satisfaction of NCI's Communication and Education Resources (NCI), 64072-64073 [2022-22959]
Download as PDF
<![CDATA[
64072
Federal Register / Vol. 87, No. 203 / Friday, October 21, 2022 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
[FR Doc. 2022–22908 Filed 10–20–22; 8:45 am]
BILLING CODE 4140–01–P
Dated: October 17, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2022–22836 Filed 10–20–22; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES
Dated: October 18, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Early-stage Development of
Data Science Technologies for Infectious and
Immune-mediated Diseases (U01 Clinical
Trial Not Allowed); Exploratory Data Science
Methods and Algorithm Development in
Infectious and Immune-mediated Diseases
(R21) Cl.
Date: November 16–17, 2022.
Time: 9:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Vanitha Sundaresa Raman,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G45,
Rockville, MD 20852, 301–761–7949,
vanitha.raman@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
19:08 Oct 20, 2022
Jkt 259001
Submission for OMB Review; 30-Day
Comment Request National Cancer
Institute (NCI) A Generic Submission
for Formative Research, Pretesting and
Customer Satisfaction of NCI’s
Communication and Education
Resources (NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ilene French,
Branch Chief, Office of Communication
and Public Liaison, National Cancer
Institute, 9609 Medical Center Drive,
Maryland 20892 or call non-toll-free
number (240) 276–7787 or email your
request, including your address to:
nciocpl@mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on August 16, 2022, (Vol 87,
No. 157, Page 50340) and allowed 60
days for public comment. One public
comment was received. The purpose of
this notice is to allow an additional 30
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
days for public comment. The National
Cancer Institute (NCI), National
Institutes of Health (NIH), may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid Office of Management
and Budget (OMB) control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, NIH has
submitted to OMB a request for review
and approval of the information
collection listed below.
Proposed Collection: A Generic
Submission for Formative Research,
Pretesting and Customer Satisfaction of
NCI’s Communication and Education
Resources (NCI), 0925–0046, Expiration
Date 11/30/2022, EXTENSION, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: This information collection
request is to approve the Generic
Submission for Formative Research,
Pretesting, and Customer Satisfaction of
NCI’s Communication and Education
Resources (NCI) for three years. As part
of NCI’s mandate from Congress to
disseminate information on cancer
research, detection, prevention, and
treatment, the Institute develops various
messages and materials. Testing these
messages and materials assesses their
potential effectiveness in reaching and
communicating with their intended
audience while they are still in the
developmental stage and can be revised.
The formative research and pretesting
process thus maximize NCI’s limited
dollar resources for information
dissemination and education. NCI also
must ensure the relevance, utility, and
appropriateness of the many
educational programs and products that
the Institute produces. Customer
satisfaction studies help NCI identify
modifications necessary to meet the
needs of NCI’s various target audiences.
Since the previous submission, there
have been six approved sub-studies
with an approved request of 13,473
burden hours over 2.5 years. Approval
is requested for the conduct of multiple
studies annually using such methods as
interviews, focus groups, and various
types of surveys. The content, timing,
and respondents included in each substudy will vary depending on the nature
of the message/material/program being
assessed, the methodology selected, and
the target audiences.
OMB approval is requested for 3
years. There are no costs to respondents
E:\FR\FM\21OCN1.SGM
21OCN1
64073
Federal Register / Vol. 87, No. 203 / Friday, October 21, 2022 / Notices
other than their time. The total
estimated annualized burden hours are
13,500.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
time per
response
(in hours)
Type of
respondents
Focus Groups, Individual In-Depth Interviews, Brief Interviews, Surveys,
Website Usability Testing.
Focus Groups, Individual In-Depth Interviews, Brief Interviews, Surveys,
Website Usability Testing.
Individuals (General Public) .....
9,000
1
45/60
6,750
Individuals (Health Care Professionals).
9,000
1
45/60
6,750
Total ...................................................
..................................................
........................
18,000
........................
13,500
Fishers Lane, Room 3G56, Rockville, MD
20852, (301) 761–6656, maryam.rohani@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 18, 2022.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2022–22959 Filed 10–20–22; 8:45 am]
BILLING CODE 4140–01–P
Dated: October 18, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2022–22906 Filed 10–20–22; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES
Number of
responses per
respondent
Form name
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: November 17, 2022.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G56,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Maryam Rohani, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
VerDate Sep<11>2014
19:08 Oct 20, 2022
Jkt 259001
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Review of Conference Grant
Applications.
Date: November 16, 2022.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Frm 00074
Fmt 4703
Sfmt 4703
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rahat (Rani) Khan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, (301) 594–7319,
khanr2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: October 17, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–22835 Filed 10–20–22; 8:45 am]
National Center for Advancing
Translational Sciences: Notice of
Closed Meeting
PO 00000
Total annual
burden hours
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2023 Notice of
Supplemental Funding Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding.
AGENCY:
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting administrative
supplements to the 54 grant recipients
funded under the FY 2022 Cooperative
Agreements for States and Territories to
Build Local 988 Capacity (988 State and
Territory Grants) Notice of Funding
Opportunity (NOFO) SM–22–015,
which have a project end date of April
2024. This supplemental funding is
within scope and is expected to increase
and/or expand original workforce
SUMMARY:
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 87, Number 203 (Friday, October 21, 2022)]
[Notices]
[Pages 64072-64073]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22959]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request National Cancer
Institute (NCI) A Generic Submission for Formative Research, Pretesting
and Customer Satisfaction of NCI's Communication and Education
Resources (NCI)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Ilene French, Branch Chief, Office of
Communication and Public Liaison, National Cancer Institute, 9609
Medical Center Drive, Maryland 20892 or call non-toll-free number (240)
276-7787 or email your request, including your address to:
[email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on August 16, 2022, (Vol
87, No. 157, Page 50340) and allowed 60 days for public comment. One
public comment was received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Cancer Institute
(NCI), National Institutes of Health (NIH), may not conduct or sponsor,
and the respondent is not required to respond to, an information
collection that has been extended, revised, or implemented on or after
October 1, 1995, unless it displays a currently valid Office of
Management and Budget (OMB) control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, NIH has submitted to OMB a request for review and approval
of the information collection listed below.
Proposed Collection: A Generic Submission for Formative Research,
Pretesting and Customer Satisfaction of NCI's Communication and
Education Resources (NCI), 0925-0046, Expiration Date 11/30/2022,
EXTENSION, National Cancer Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information Collection: This information collection
request is to approve the Generic Submission for Formative Research,
Pretesting, and Customer Satisfaction of NCI's Communication and
Education Resources (NCI) for three years. As part of NCI's mandate
from Congress to disseminate information on cancer research, detection,
prevention, and treatment, the Institute develops various messages and
materials. Testing these messages and materials assesses their
potential effectiveness in reaching and communicating with their
intended audience while they are still in the developmental stage and
can be revised. The formative research and pretesting process thus
maximize NCI's limited dollar resources for information dissemination
and education. NCI also must ensure the relevance, utility, and
appropriateness of the many educational programs and products that the
Institute produces. Customer satisfaction studies help NCI identify
modifications necessary to meet the needs of NCI's various target
audiences. Since the previous submission, there have been six approved
sub-studies with an approved request of 13,473 burden hours over 2.5
years. Approval is requested for the conduct of multiple studies
annually using such methods as interviews, focus groups, and various
types of surveys. The content, timing, and respondents included in each
sub-study will vary depending on the nature of the message/material/
program being assessed, the methodology selected, and the target
audiences.
OMB approval is requested for 3 years. There are no costs to
respondents
[[Page 64073]]
other than their time. The total estimated annualized burden hours are
13,500.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Type of Number of responses per per response Total annual
respondents respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Focus Groups, Individual In- Individuals 9,000 1 45/60 6,750
Depth Interviews, Brief (General
Interviews, Surveys, Website Public).
Usability Testing.
Focus Groups, Individual In- Individuals 9,000 1 45/60 6,750
Depth Interviews, Brief (Health Care
Interviews, Surveys, Website Professionals).
Usability Testing.
---------------------------------------------------------------
Total..................... ................ .............. 18,000 .............. 13,500
----------------------------------------------------------------------------------------------------------------
Dated: October 18, 2022.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer Institute, National
Institutes of Health.
[FR Doc. 2022-22959 Filed 10-20-22; 8:45 am]
BILLING CODE 4140-01-P
